E-mail this story
MedImmune creating drug pipeline for AstraZeneca
When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up."
By Scott Dance, The Baltimore Sun
November 18, 2012